Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730 PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In…[...]
Read More
Introduction Interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), represents a group of chronic, progressive lung disorders characterized by inflammation and scarring of lung tissue. Since the rollout of…[...]
Read More
📚 Background and Etiology Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), affects 10–30% of individuals post-infection, with symptoms persisting beyond three months. Edema—fluid accumulation in tissues—has emerged as…[...]
Read More
Peter C. Gøtzsche, Maryanne Demasi, doi: https://doi.org/10.1101/2022.12.06.22283145 Abstract BACKGROUND Serious and severe harms of the COVID-19 vaccines have been downplayed or deliberately excluded by the study sponsors in high impact medical journals. METHODS Systematic review of…[...]
Read More
Saya Masutani • Toru Miwa • Kishiko Sunami, DOI: 10.7759/cureus.84123 Abstract The pathophysiology of coronavirus disease 2019 (COVID-19) remains elusive, although it has been associated with symptoms such as dizziness and vertigo. Here, we report…[...]
Read More
Annika Kim Constantino@annikakimc Key Points The Food and Drug Administration is considering revoking its authorization of Pfizer’s Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed…[...]
Read More
Introduction COVID-19 mRNA vaccines were developed with unproven and risky speed and deployed globally to combat a novel virus. While they have reduced severe disease in some populations, emerging peer-reviewed…[...]
Read More
The following is a summary of “A biopsychosocial analysis of risk factors for persistent physical, cognitive, and psychological symptoms among previously hospitalized post-COVID-19 patients,” published in Scientific Reports by Claessens et…[...]
Read More
Financial Times‘ Groundbreaking’ research finds ‘genetic signals’ for the long-stigmatized illness People with chronic fatigue syndrome have a different genetic profile to the general population, with DNA variations in their…[...]
Read More
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person…[...]
Read More